Morgan Stanley Johnson & Johnson Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Johnson & Johnson stock. As of the latest transaction made, Morgan Stanley holds 45,162,129 shares of JNJ stock, worth $6.99 Billion. This represents 0.54% of its overall portfolio holdings.

Number of Shares

45,162,129

Previous 42,069,269 7.35%

Holding current value

$6.99 Billion

Previous $6.15 Billion 19.03%

% of portfolio

0.54%

Previous 0.48%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $450 Million - $518 Million	3,092,860 Added 7.35%	45,162,129 $7.32 Billion
Q2 2024 Oct 17, 2024	SELL	$144.38 - $157.78 $69.4 Million - $75.8 Million	-480,674 Reduced 1.13%	42,069,269 $6.15 Billion
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $69.4 Million - $75.8 Million	-480,674 Reduced 1.13%	42,069,269 $6.15 Billion
Q1 2024 Oct 17, 2024	BUY	$155.22 - $162.74 $74.6 Million - $78.2 Million	480,674 Added 1.14%	42,549,943 $6.73 Billion
Q1 2024 Aug 16, 2024	BUY	$155.22 - $162.74 $138 Million - $145 Million	890,464 Added 2.14%	42,549,943 $6.73 Billion
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $138 Million - $145 Million	890,464 Added 2.14%	42,549,943 $6.73 Billion
Q4 2023 Aug 16, 2024	SELL	$145.6 - $158.88 $59.7 Million - $65.1 Million	-409,790 Reduced 0.97%	41,659,479 $6.53 Billion
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $60.3 Million - $65.8 Million	414,378 Added 1.0%	41,659,479 $6.53 Billion
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $66.1 Million - $74 Million	-424,118 Reduced 1.02%	41,245,101 $6.42 Billion
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $257 Million - $277 Million	1,665,699 Added 4.16%	41,669,219 $6.9 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $335 Million - $400 Million	-2,221,001 Reduced 5.26%	40,003,520 $6.2 Billion
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $724 Million - $813 Million	4,521,062 Added 11.99%	42,224,521 $7.46 Billion
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $34.3 Million - $38.2 Million	-212,552 Reduced 0.56%	37,703,459 $6.16 Billion
Q2 2022 Oct 27, 2022	BUY	$168.19 - $186.01 $2 Billion - $2.21 Billion	11,903,316 Added 45.76%	37,916,011 $6.73 Billion
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $2 Billion - $2.21 Billion	11,903,316 Added 45.76%	37,916,011 $6.73 Billion
Q1 2022 Oct 27, 2022	SELL	$158.14 - $179.59 $1.88 Billion - $2.14 Billion	-11,903,316 Reduced 31.39%	26,012,695 $4.61 Billion
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $40.9 Million - $46.5 Million	258,860 Added 1.01%	26,012,695 $4.61 Billion
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $134 Million - $148 Million	857,814 Added 3.45%	25,753,835 $4.41 Billion
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $4.02 Billion - $4.47 Billion	24,896,021 New	24,896,021 $4.02 Billion

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account